NCT04012268View on ClinicalTrials.gov

The Safety and Efficacy of RIC on Adult Moyamoya Disease

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

November 10, 2020

Study Completion Date

February 2, 2021

Conditions
Moyamoya Disease
Interventions
DEVICE

RIC

Patients allocated to the RIC group will undergo RIC procedure during which bilateral arm cuffs are inflated to a pressure of 50 mmHg over systolic blood pressure for five cycles of 5 min followed by 5 min of relaxation of the cuffs.

DRUG

Aspirin

patients will accept medication guided by neurologists

Trial Locations (1)

100053

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Capital Medical University

OTHER

NCT04012268 - The Safety and Efficacy of RIC on Adult Moyamoya Disease | Biotech Hunter | Biotech Hunter